1, such as the characterization of ADA positives to be explored only ... starting point for reflection at the time of planning immunogenicity studies as part of clinical trials; however, they ...
1 This immunogenicity is associated with ADA generation, which can neutralize drug efficacy by altering its pharmacokinetic and pharmacodynamic properties. Above all, ADAs may cause several immune ...
solutions streamline testing workflows for detecting anti-drug antibodies (ADA) and neutralizing antibodies (NAb).
The Gyrolab Generic Rodent ADA Kit fills an industry-wide need for a generic assay solution to expedite immunogenicity assessment. The new bioanalysis kit is optimized for use on all Gyrolab ...